Newsbenzinga
Adial Pharmaceuticals Expects Phase 1 Start For Ulcerative Colitis Drug AT177 In H1 2027 Vs Prior H2 2027 Target
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…